Search - tctmd.com

Displaying 201 - 220 of 676

Sort: Relevancy | Date

Presentation TCT 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Presenter: Michael Bloch

November 04, 2021

Presentation TCT 2021

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Presenter: Herbert D. Aronow

November 04, 2021

Presentation TCT 2021

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Presenter: Michael A. Weber

November 04, 2021

Presentation TCT 2021

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Presenter: Debbie Cohen

November 04, 2021

Presentation TCT 2021

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Presenter: Ajay Kirtane

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

Presentation TCT 2021

TCT 676: Emergent Thrombectomy of Right Ventricular Thrombus and Massive Pulmonary Emboli using Inari FlowTriever

Presenter: Qasim Jehangir

November 04, 2021

Presentation TCT 2021

TCT 675: Massive Pulmonary Embolism Requiring VA ECMO, Percutaneous Thrombectomy, and Ultimately Surgical Embolectomy

Presenter: Robert Zilinyi

November 04, 2021

Presentation TCT 2021

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Presenter: Mikhail Tarasov

November 04, 2021

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

Presentation TCT 2020

I Recommend Renal Denervation!

Presenter: Andrew Sharp

October 17, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TCT 626: Recurrent Hemothorax Complicating VA-ECMO following tPA for Massive Pulmonary Embolism

Presenter: Rami Zein

October 14, 2020

Presentation TCT 2020

TCT 537: Pulmonary Artery Intervention for Submassive Pulmonary Embolism From a Convenient and Safe Arm Superficial Venous Access

Presenter: Hady Lichaa

October 14, 2020

Advertisement

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

TCT 677: Renal denervation in a young patient with malignant hypertension

TCT 676: Emergent Thrombectomy of Right Ventricular Thrombus and Massive Pulmonary Emboli using Inari FlowTriever

TCT 675: Massive Pulmonary Embolism Requiring VA ECMO, Percutaneous Thrombectomy, and Ultimately Surgical Embolectomy

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Good Long-term Results With FANTOM BVS, but More Data Needed

Treating Accessory Arteries May Be Important in Renal Denervation

I Recommend Renal Denervation!

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TCT 626: Recurrent Hemothorax Complicating VA-ECMO following tPA for Massive Pulmonary Embolism

TCT 537: Pulmonary Artery Intervention for Submassive Pulmonary Embolism From a Convenient and Safe Arm Superficial Venous Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content